Maryland Senate Bill 819 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on February 4 2019 - 25% progression, died in committee
Action: 2019-02-18 - Hearing 3/06 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Requiring the Secretary of Health, by a certain date each year, to identify a certain number of certain prescription drugs on which the State spends a certain amount of money; requiring the Secretary to require a certain pharmaceutical manufacturer to report certain cost changes and expenditures during a certain period of time; requiring the Secretary, by a certain date each year, to publish a report on the Maryland Department of Health's website based on the information the Secretary receives under certain provisions of the Act; etc.

Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting

Sen. Antonio Hayes [D]

Sen. Stephen Hershey [R]

Date	Chamber	Action
2019-02-18	Senate	Hearing 3/06 at 1:00 p.m.
2019-02-18	Senate	Hearing canceled
2019-02-11	Senate	Hearing 3/13 at 1:00 p.m.
2019-02-04	Senate	First Reading Finance

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0819?ys=2019rs
Text	https://mgaleg.maryland.gov/2019RS/bills/sb/sb0819f.pdf
Supplement	https://mgaleg.maryland.gov/2019RS/fnotes/bil_0009/sb0819.pdf